Biologically active vasopressin agonist metabolites

Details Biologically active vasopressin agonist metabolites Biologically active vasopressin agonist metabolites

2006-11-21

2006-11-21

Coleman, Brenda (Department: 1624)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Heterocyclic carbon compounds containing a hetero ring...

C540S561000

Reexamination Certificate

active

07138393

ABSTRACT:
Novel compounds of Formula (I)and pharmaceutically acceptable salts thereof, and pharmaceutical formulations containing such compounds which are useful as anti-aquaretic agents in the treatment of nocturnal urinary enuresis, nocturnal urinary urgency, and/or similar conditions.

REFERENCES:
patent: 3326900 (1967-06-01), Schmidt et al.
patent: 4766108 (1988-08-01), Ali
patent: 5055448 (1991-10-01), Manning et al.
patent: 5070187 (1991-12-01), Gavras et al.
patent: 5420270 (1995-05-01), Chandrakumar et al.
patent: 5512563 (1996-04-01), Albright et al.
patent: 5516774 (1996-05-01), Albright et al.
patent: 5521173 (1996-05-01), Venkatesan et al.
patent: 5536718 (1996-07-01), Albright et al.
patent: 5612334 (1997-03-01), Alright et al.
patent: 5880122 (1999-03-01), Trybulski et al.
patent: 6194407 (2001-02-01), Failli et al.
patent: 6268360 (2001-07-01), Failli et al.
patent: 0127135 (1984-12-01), None
patent: 0306860 (1989-03-01), None
patent: 0472166 (1992-02-01), None
patent: 0636625 (1995-02-01), None
patent: 0990650 (2000-04-01), None
patent: 4999 (1967-05-01), None
patent: 0881460 (1996-03-01), None
patent: WO 95/34540 (1995-12-01), None
patent: WO 96/22282 (1996-07-01), None
patent: WO 97/22591 (1997-06-01), None
patent: WO 99/06409 (1999-02-01), None
patent: WO00/46228 (2000-08-01), None
patent: WO 01/22942 (2001-04-01), None
patent: WO 01/22969 (2001-04-01), None
patent: WO 01/49682 (2001-07-01), None
patent: WO 02/00626 (2002-01-01), None
Derwent Abstract, 98-077100/07 (WO 97/49707).
Katritzky et al., “Efficient conversion of nitriles to amides with basic hydrogen peroxide in dimethyl sulfoxide,”Synthesis(1989) pp. 949-950.
Hales et al. “Rearrangement reactions of bicyclic systems. Part V. 1 Acid-catalysed rearrangements of 1,4-dihydro-1,5,8-trimethoxy-1,4-ethenonaphthalene and the remarkable effect of aromatic methoxy-groups on the course of the reaction,”Tedtahedron(1995) 51(27):7403-7410.
Cervoni, P. and Chan, P.S., Diuretic Agents, in Kirk-Othmer: Encyclopedia of Chemical Technology, 4th Ed., Wiley, vol. 8, 398-432, 1993.
Jackson, E.K., Goodman's and Gilman's The Pharmacological Basis of Therapeutics, 9th Ed., Eds, Hardman, Limbird, Molinoff, Ruddon and Gilman, McGraw-Hill, New York, pp. 715-731, 1996.
Alami et al., Tetrahedron Lett., 34, 6403, (1993).
Albini, A., Synthesis, 263 (1993).
Brenes-Pereira, C., Texas Heart Institute Journal, 24 (2), 118 (1997).
Burggraaf, J. et al., Clin. Sci. 86, 497 (1994).
Cabri et al., Tetrahedron Lett., 32, 1753 (1991).
Cash, J.D. et al., Brit. J. Haematol, 27, 363 (1974).
Cecchi, L. et al., J. Het. Chem., 20, 871 (1983).
Coffen et al., J. Org. Chem., 49, 296 (1984).
Coppola et al., J. Het. Chem., 11, 51 (1974).
Craig et al., Tetrahedron Lett., 4025 (1979).
David, J-L., Regulatory Peptides, 45, 311 (1993).
du Vigneaud, V. et al., J. Am. Chem. Soc., 76, 4751 (1954).
Farina et al., J. Org. Chem., 59, 5905 (1994).
Hallstrom, et al., Tetrahedron Lett., 667 (1980).
Huguenin et al., Helv. Chim. Acta, 49, 695 (1966).
Inanaga et al., Bull. Chem. Soc. Jpn., 52, 1989 (1979).
Jones, R.A., Aldrichimica ACTA, 9(3), 35 (1976).
Kantlehner et al., Chem. Ber., 105, 1340 (1972).
Khuthier, A-H. et al., J. Chem. Soc. Chem. Commun., 9 (1979).
Klaubert, D.H., J. Het. Chem., 22, 333 (1985).
Knorr et al., J. Org. Chem., 49, 1288 (1984).
Kosugi et al., Bull. Chem. Soc. Jpn., 60, 767 (1987).
Lethagen, S., Ann. Hematol., 69, 173 (1994).
Ligouri et al., Tetrahedron, 44, 1255 (1988).
Lin et al., J. Het. Chem., 14, 345 (1977).
Manning et al., J. Med. Chem., 35, 3895 (1992).
Manning et al., J. Med. Chem., 35, 382 (1992).
Martina et al., Synthesis, 8, 613 (1991).
Martinez et al., J. Med. Chem., 35, 620 (1992).
Mayet et al., J. of the Royal College of Physicians of London, 31 (3), 313 (1997).
Murray, R.W., Chem. Rev., 1187 (1989).
Oliver et al., J. Physiol. (London), 18, 277 (1895).
Reed et al., J. Org. Chem., 52, 3491 (1987).
Ruffolo et al., Drug News and Perspective, 4(4), 217 (May 1991).
Sonogashira et al., Tetrahedron Lett., 4467 (1975).
Street et al., J. Med. Chem., 36, 1529 (1993).
Williams, P.D., J. Med. Chem., 35, 3905 (1992).

Affiliated with

Also associated with

Rating

Biologically active vasopressin agonist metabolites does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Biologically active vasopressin agonist metabolites, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Biologically active vasopressin agonist metabolites will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3666051